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ASSOCIATIONS BETWEEN ATHEROGENIC MARKERS AND HEARING LOSS:
NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY: 2011-2012,
2015-2016
Anna Rombakh
June 2022

Importance Hearing loss (HL) is a major public health problem that has been previously
found to be associated with abnormal atherogenic markers.
Objective To investigate the associations between such atherogenic markers and the
degree of HL using continuous NHANES data from cycle years 2011-2012 and 20152016.
Design, Study, and Participants This observational study used data from two National
Health and Nutrition Examination Survey (NHANES) cycle years 2011-2012 and 20152016. NHANES continuously conducts data collection via home interviews and physical
exams completed in their Mobile Examination Centers. NHANES participants ages 20-69
who partook in audiometry, anthropometric and laboratory testing were included. Data
was analyzed from 2011-2012 and 2015-2016 cycle years.
Exposures Substantial hearing loss was defined as a HL degree of moderate (41-55dB)
or higher at any frequency.
Main Outcomes and Measures Risk of hypercholesterolemia was defined as ≥ 240
mg/dL, hypoalphalipoproteinemia or low levels of high-density lipoprotein cholesterol as
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< 40 mg/dL for males and < 50 mg/dL for females, elevated low-density lipoprotein
cholesterol as ≥ 160 mg/dL, hypertriglyceridemia was defined as ≥ 175 mg/dL, elevated
levels of Apolipoprotein B as ≥ 130 mg/dL and elevated non-high-density lipoprotein
cholesterol as ≥ 190 mg/dL. Associations between abnormal atherogenic markers and
substantial HL were determined in adjusted multivariate logistic regression models, ttests and chi-square analysis.
Results Among 8955 participants there were significant associations between gender,
age, BMI and race/ethnicity and substantial hearing loss (p<.0001). No significant
differences were identified between people with normal and substantial hearing loss in
regards to mean concentrations of total cholesterol, low-density lipoprotein cholesterol
(LDL-C), high-density lipoprotein cholesterol (HDL-C), non-high density lipoprotein
cholesterol (non-HDL-C), and apolipoprotein B cholesterol (ApoB). Significant
differences were identified between prevalence of triglycerides and substantial hearing
loss (p<.0001). Multivariate logistic regression models found that after adjusting for
covariates there was no significant association between having hypertriglyceridemia and
substantial hearing loss (OR 1.2, 95% CI, 0.8-1.8).
Conclusions and Relevance This study’s results showed no association between
atherosclerosis markers and degree of hearing loss. However, due to conflicting findings
of several studies on this topic, further research should be done to determine if lipid
markers can affect hearing loss.
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CHAPTER 1
INTRODUCTION
In 2019, hearing loss (HL) affected an estimated 1.5 billion of the global
population, contributing to the third most common cause of years of living with disability
(YLDs).1 HL is commonly believed to be caused by noise exposure or aging, but still
largely remains a major public health problem with an unclear etiology. HL in midlife
has also been estimated to be associated with 9% of dementia cases, increasing an
individual’s level of cognitive impairment and leading to social isolation.2,3
HL can be caused by damage or dysfunction of the peripheral and/or central
auditory system from the external ear to the cerebral auditory cortex. HL type can be
categorized as sensorineural (cochlear or spiral ganglion impairment), conductive (outer
or inner ear impairment) or mixed.4 Mechanisms currently under investigation for HL
includes development of reactive oxygen species (ROS) and oxidative stress possibly
caused by antioxidant imbalances,5,6 and the “lipid hypothesis”. The current possible
explanation for the “lipid hypothesis” is that as atherosclerosis markers such as total
serum cholesterol elevate, blood viscosity will increase contributing to atherosclerosis of
arteries such as the internal auditory artery (IAA). The IAA is responsible for supplying
blood to the cochlea, auditory nerve, and the stria vascularis (SV) which is located at the
wall of the cochlea.7 When blood supply to the SV is constricted, vital nutrients are
unable to be supplied to hair cells, also known as stereocilia, leading to the irreversible
damage of hair cells and diminished hearing sensitivity.8 This type of damage has been
seen in numerous studies in individuals with cardiovascular disease, diabetes, chronic
kidney disease and in individuals with dyslipidemia.9-13 Similarly, an observational study
8

utilizing data from the National Health and Nutrition Examination Survey (NHANES)
examining the relationship between risk factors of hearing loss and diabetes identified
that individuals with low high-density lipoprotein and elevated total cholesterol where
more likely to be hearing impaired.9
The original study on this lipid hypothesis investigated hearing levels of
members of the southeast Sudan tribe, known as the Mabaans. Living in a noise-free
environment, researchers Rosen and colleagues sought out to research the possible
associations between vascular changes such as blood pressure, cholesterol and hearing
loss compared to healthy adults living in the United States. Rosen et al., identified that
there was a positive inverse relationship with better hearing being associated with
lowered cholesterol levels. They also concluded that although noise exposure is an
obvious and large component in hearing loss, other factors such as nutrition, vascular
changes, stress, climate, and genetic factors play a more significant role then previously
known at the time. This inspired many to continue examining the relationship of blood
lipids and hearing loss.14
In an experimental study done in 1997, Nguyen and Brownell identified that
lipidosis of the inner ear may be a mechanism of vascular changes affecting hearing.
Nguyen identified in guinea pig cochlea that cholesterol has varied distributions among
outer stereocilia membranes, and when cholesterol is integrated in such cells, lateral wall
stiffness increases, possibly contributing to hearing impairment.15 Therefore, the purpose
of this observational study was to investigate the associations between such atherogenic
markers and the degree of hearing loss using continuous NHANES data from cycle years
2011-2012 and 2015-2016.
9

LITERATURE REVIEW
Hearing Loss
Prevalence and Mechanisms
As of 2019, 1.57 billion people experienced hearing loss (HL) globally.1
Accounting for 20.3% of the global population, those experiencing HL are
inconvenienced with economic burden, social isolation, cognitive impairment, and
depression or anxiety.2-4 According to the Global Burden of Disease Study 2019, the
number of individuals with moderate to complete hearing loss has increased by 79.1%
since 1990.1 This rapid increase of HL prevalence is concerning according to the World
Health Organization (WHO), yet it is not getting the proper awareness by public health
officials and society.16Although one may speculate that this rapid increase can be
attributed to the expeditious aging population (>60 years), which is projected to double
by 2050.17 HL has also been studied to be correlated with disorders such as dementia in
older adults,3 speech and language developmental delays in children,18 and diseases such
as diabetes, hypertension, chronic kidney disease and cardiovascular disease.13
There are various types of HL, which can be classified as either conductive
(damage of outer or middle ear), sensorineural (impairment in the cochlea or spiral
ganglion) or mixed (both conductive and sensorineural). The peripheral auditory system
which is responsible for converting sound energy into neural signals, is comprised of the
outer, middle, and inner ear (cochlea). The hair cells (also known as stereocilia) of the
cochlea are supplied nerve signals by the neurons of the spiral ganglion, which are
signaled centrally to the auditory nuclei of the brain stem via the auditory nerve.
Mammalian cochlea stereocilia are vulnerable to irreversible damage from various
10

stressors, and are not regenerated, therefore when damage to the hair cells is present, it is
permanent.19
Auditory testing is commonly performed using pure tone air conduction
audiometry (PTA). This type of audiometry testing examines sensitivity of hearing by
presenting an individual with pure tone signals to each ear through earphones at varied
intensity.20 Hearing threshold is determined by the softest sound an individual can hear at
each frequency 50 percent of the time, using frequencies vital to human
communication14. Sensitivity of PTA testing has been set at 92 percent, with a specificity
of 94 percent in diagnosing sensorineural hearing loss.21,22
HL causes are multifactorial, ranging from aging processes, genetics, noise, and
environmental exposures, or idiopathic. Sex differences have also been reported for HL,
with males being more likely to experience HL compared to women. This can be
accredited to men being more likely to work in occupations exposed to workplace noise,
according to a Canadian study.23 As previously mentioned, chronic diseases have been
examined for their correlations with HL, with cardiovascular disease risk factors being a
focus of literature since 1965, when the original study was published by Rosen and Olin
on the possible association of HL and elevated serum cholesterol and blood pressure.14,24
Associations with Hearing Loss
Dyslipidemia
Recently, chronic diseases have been examined in literature for their association
with HL. Dyslipidemia is a known risk factor for cardiovascular disease and can be
defined as elevated atherogenic markers such as total serum cholesterol (TC), low-density
lipoprotein cholesterol (LDL-C), triglycerides, apolipoprotein B (ApoB) or low levels of
11

high-density lipoprotein cholesterol (HDL-C). However, recent studies have also made
claims that non-high density lipoprotein (non-HDL-C) may be a better atherogenic
marker to include when analyzing for risk of cardiovascular disease.25-27 Non-HDL-C is
calculated by subtracting HDL-C from TC and does not require a fasted blood sample. It
also encompasses LDL-C and very low lipoprotein cholesterol (VLDL-C), therefore
including all apolipoprotein B lipoproteins,19 LDL-C, an important pro-atherogenic
lipoprotein, inhabits cholesteryl ester and TG inside the particle, and apolipoproteins on
the surface. The main transporter of TG is VLDL-C, and when lipolysis of this particle
occurs, LDL-C is created.27 LDL-C is considered vital in CVD risk assessment, as it is
responsible for cholesterol transport to tissues which accumulates in the plasma. When
the cholesterol component of LDL-C is deposited in the endothelium of the arteries,
development of atherosclerosis occurs. ApoB, a primary apolipoprotein of LDL-C, has
also been found to be related to cardiovascular disease risk when elevated. HDL-C, the
smallest lipoprotein found in plasma, plays an influential role in reverse cholesterol
transport, a system in the body that reverses atherosclerosis processes. Therefore, low
levels of HDL-C are at as a large component of cardiovascular disease risk.28
Dyslipidemia is currently on the rise in the United States, with current prevalence
at 49.2% and increasing with age.27 Dyslipidemia and its relationship with HL is
controversial, as many studies have conflicting findings. Researchers Rosen and Olin in
1965, identified that there was a positive inverse relationship with better hearing and
lowered serum cholesterol levels.24 Lee and researchers also identified that elevated TC
and TG levels were significantly associated with an increased prevalence of sensorineural
hearing loss.29 Elevated TG levels were identified as possible risk factors for hearing loss
12

caused by noise exposure in a study done by Chang et al.,26 yet Gold and researchers did
not identify a significant association in their study done in 1989,25 Related results were
found in a study done by Helzner et al., where the association between cardiovascular
disease (CVD) and risk factors with age-related hearing loss (presbycusis) were assessed
in a population of black and white older adults.8 This cross-sectional cohort study
recruited 2,049 healthy adults to undergo pure-tone audiometry testing as well as CVD
history and risk factors. Helzner and researchers found that elevated levels of TG and
high BMI (especially among women) were significantly associated with diminished
auditory function. On the contrary, researchers in a Norway study found, surprisingly,
that elevated levels of HDL-C and lowered levels of LDL-C and TC had protective
effects on hearing.30 Marlow et al., also found that when assessing the relationship
between hearing impairment and undiagnosed diseases such as hyperlipidemia, there was
no significant difference between adults with hearing impairment and adults with usual
hearing.13
As previously mentioned, recently non-HDL-C has been studied as a better
marker for cardiovascular disease then other atherogenic markers. In a recent study
evaluating the association of non-HDL-C and risk of sensorineural hearing loss using
Korean Health and Nutrition Examination Survey (KNHANES), researchers identified
that elevated non-HDL-C was significantly associated with an increased risk, possibly
making non-HDL-C a valuable tool in predicting sensorineural hearing loss risk.31
Similarly, researchers Ballesteros and colleagues evaluated genetic and acquired risk
factors of individuals dealing with sudden sensorineural hearing loss and if there was a
correlation with cardiovascular risk factors. They found that there was a positive
13

association between abnormal lipid profiles and increased risk of sensorineural hearing
loss, yet researchers concluded that multi-causality should be further researched in risk of
sensorineural hearing loss.32
Dyslipidemia and Hearing Loss Mechanisms
Possible explanations for arteriosclerotic changes being involved in hearing loss
has been explained by multiple theories. The current possible explanation is that as
atherosclerosis markers such as TC elevate, blood viscosity will increase contributing to
atherosclerosis of arteries such as the internal auditory artery (IAA). The IAA is
responsible for supplying blood to the cochlea, auditory nerve and the stria vascularis
(SV) which is located at the wall of the cochlea.8When blood supply to the SV is
constricted, vital nutrients are unable to be supplied to stereocilia, leading to the
irreversible damage of stereocilia and diminished hearing sensitivity.25 As previously
mentioned, several studies have identified correlations with hypertriglyceridemia with an
increased risk of having hearing loss. This can be perhaps explained by an experimental
study done by Skeggs et al., in which it was identified that isolated enrichment of
triglycerides adequately activates the alteration of cholesterol removal and delivery
mechanisms, possibly leading to a diminished function of the endothelium33 and reduced
microcirculation of the cochlea.
BMI and Hearing Loss
Several studies have emphasized that elevated BMI or obesity may be correlated
with an increased risk of hearing loss.34 Due to obesity already having numerous comorbidities including hypertension, cardiovascular disease, diabetes, and dyslipidemia
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that have also been associated with increased risk of hearing loss, many researchers have
aimed to examine if such relationships exist with hearing loss as well.35
In a retrospective longitudinal study utilizing data from the Nurses’ Health Study
II, researchers examined associations of elevated BMI, waist circumference, physical
activity, and self-reported hearing loss in women. They identified that women with an
elevated BMI are at an increased risk of hearing loss.36 Similarly in a cross-sectional and
longitudinal prospective study, researchers in Korea identified that higher levels of TC,
TG, and BMI were significantly associated with an increased risk of sensorineural
hearing loss.29 However, in a retrospective cohort study done in Taiwan, researchers did
not identify any significant association with sensorineural hearing loss diagnosis.37
Positive inverse relationships have also been identified in many studies
researching the associations of cardiovascular risk factors and elevated BMI. In a recent
cross-sectional study conducted in Australia, researchers aimed to assess relationships
between hearing loss and cardiovascular risk factors using data from a larger communitybased population study. Tan et al., found that obesity, elevated TC, and lowered HDL-C
were all associated with an increased prevalence of hearing loss.38 On the contrary,
Sharagorodsky and researchers examined cardiovascular risk factors and incident hearing
loss in men, and identified that a history of elevated cholesterol was associated
independently to risk of hearing loss, yet elevated BMI was not found to be associated
with hearing loss risk.39 Similarly, researchers Lohi and colleagues, researched the
relationship of hearing impairment and cardiovascular disease, and did not identify a
significant association between cardiovascular disease and hearing loss in the crosssectional study. However, elevated BMI was identified as more common in men with
15

hearing loss.40 The linear relationship of elevated BMI and hearing loss, seems to be
supported by many studies, although due to elevated BMI being also associated with
many other confounding factors such as cardiovascular disease risk, hypertension, and
diabetes, it’s vital for further research to be done to better understand if elevated BMI is
independently responsible for hearing loss risk.
Elevated BMI and Hearing Loss Mechanisms
Proposed mechanisms behind elevated BMI or obesity and hearing impairment
are not fully understood in literature, nevertheless there are several possible explanations.
Researchers have proposed that lifestyle factors such as lack of physical activity and
overconsumption of specific foods such as foods high in trans-fat and saturated fat, leads
to increased risk of cardiovascular disease contributing to hearing loss risk. This outcome
was examined in a longitudinal cohort study evaluating associations between healthy
dietary patterns and risk of hearing loss in women. Researchers identified that in fact
when women had followed the DASH diet, they had a lowered risk of hearing loss.41
Another proposed mechanism identified in the relationship between obesity and
hearing loss is lowered levels of adiponectin, an anti-inflammatory adipokine associated
with obesity and other metabolic disorders. Adiponectin is also involved in the regulation
of insulin sensitivity, metabolism, and atherosclerosis. When elevated, adiponectin has
been linked to an inverse relationship with high-frequency hearing loss, implying that
low levels may lead to hearing impairment.42 This relationship was proven in two
experimental animal studies conducted on mice. The first study, conducted by Wu et al.,
aimed to observe the function of adiponectin in hearing loss by examining genotypes
associated with polymorphisms of the adiponectin gene. Researchers recruited Han
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Chinese volunteers aged 40-80 years to establish a cohort for research on adiponectin
genotypes. In addition, these researchers also studied mature mice to confirm the role of
adiponectin in hearing loss in this study’s experiment. Wu et al., identified that the
adiponectin genotypes show effects on hearing levels when plasma adiponectin levels
fluctuate, and this finding was further established in mice cochlea.43 Similarly, a study
done by Tanigawa et al., was one of the first to show the relationship of adiponectin
deficiency and hearing loss in mice. These researchers identified that when mice were
supplemented with adiponectin, hearing loss was prevented, and multivariate logistic
regression analysis indicated that adiponectin was indeed an independent factor in
predicting hearing loss in mice.44
Race/Ethnicity
Observational studies analyzing associations between race/ethnicity and hearing
loss have identified that there is a 60-70% decreased odds of noise-induced hearing loss
amongst non-Hispanic blacks compared to non-Hispanic whites.45-47 In a study
examining the relationship between risk factors for hearing loss amongst those with
diabetes utilizing NHANES data, it was identified that even though non-Hispanic blacks
and Mexican Americans were more likely to have diabetes compared to other racial
groups, they had a lower prevalence of hearing loss.9 One epidemiological study
proposed that this may be related to skin color and melanocytes. Melanocytes in the
cochlea, which produce melanin have been studied to act protective against free radicals,
resulting in less hearing impairment.48 Nevertheless, it is vital for more research to be
done on the subject of mechanisms behind the differences in hearing impairment amongst
race/ethnicities.
17

Age-Related Hearing Loss
Hearing loss is often thought of as an inevitable outcome of aging, yet age-related
hearing loss (AHL) or presbycusis is a multifactorial degenerative disorder that is not yet
fully understood. AHL has high prevalence among older adults, effecting an estimated
50% of those years 70 and over, to a degree that affects their daily life.45 As previously
mentioned, HL has been found to be related to many secondary outcomes such as
increased morbidity, economic burden, social isolation, dementia and depression or
anxiety.2-4 AHL can be defined as hearing loss that is unexplainable by known otologic
diseases, ototoxins, or genetic factors.49 Several studies have proposed that AHL is
multicausal, an outcome of acquired (e.g. hereditary) or external factors (e.g. noise,
injury) impacting the inner year over decades of time, leading to hearing impairment.50
Age-Related Hearing Loss Mechanisms
AHL or Presbycusis develops in the inner ear, and due to the location of the inner
ear being deep within the temporal bone, medical professionals are unable to complete a
biopsy while the individual is alive. Histology of tissues within the inner ear after death
have shown that AHL is associated with deterioration of the SV, and less associated with
damage of the stereocilia,51 which was also confirmed in studies with aging gerbils.52,53
Correspondingly, another proposed mechanism for AHL, reactive oxygen species
(ROS), have been studied to play a large part in the decline of cochlear cells within the
aging process. ROS, a biproduct from the mitochondrial metabolism throughout the
generation of ATP are potentially damaging to cell components.6 This oxidative damage
accrues, leading to tissue damage with aging.54 To control for damage of the ROS, an
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antioxidant system is in place, in which antioxidant scavengers, and enzymes, including
superoxide dismutase, catalase, and glutathione peroxidase (Gpx).55 Studies have shown
that Gpx activity is accelerated in the SV of cochlea in older rats, confirming hypotheses
that AHL is most likely associated with the deterioration of the SV. 56
Noise-Related Hearing Loss
Noise-related HL, like other types of hearing loss has a complex etiology and not
one known independent cause. Known as a type of sensorineural hearing loss, noiseinduced HL is correlated with an exposure of noise for prolonged periods of time. In
2017, WHO estimated that 1.1 billion young people between ages 12-35, will experience
hearing loss due to an over exposure to noise.16 It has been hypothesized that any sound
over 85 dB can increase the likelihood of developing noise-induced hearing loss, which
can be a result of work-related (e.g. construction) or recreational noise exposure (e.g.
music festivals).57 Progressive hearing loss is a common symptom of noise-related
hearing loss, with moderate and temporary exposure leading to recovery after hours or
days.58 Similarly to other hearing loss, noise-induced HL can be explained by oxidative
stress damage from ROS, inflammation in the cochlea, or genetic/hereditary factors.59
National Health and Nutrition Examination Survey
The National Health and Nutrition Examination Survey (NHANES), developed in
the 1960s, was originally piloted as a series of surveys focusing on diverse populations
and/or health topics in the United States. This eventually developed into a continuous
program with evolving health focuses, used to better assess the current health and
nutritional status of individuals residing in the US. This vital data is acquired through
interviews and physical examinations and examines a nationally representative sample of
19

an estimated 5,000 US residents each year. NHANES’ at-home interview portion of data
collection includes questions about socioeconomic state, nutritional status, medical
history, and demographics. Physical examination involves examination of medical,
dental, physiological and laboratory measurements completed in their Mobile
Examination Center (MEC). To increase reliability of data, NHANES oversamples
individuals of Mexican-American, non-Hispanic Asian, non-Hispanic Black, and nonHispanic White ethnicity over the age of 60 years. Individuals participating in NHANES
are all given a specific sample weight, representative of the United States civilian noninstitutionalized Census populace. NHANES does not represent the population of those
institutionalized, which includes those residing in nursing homes, hospitals, military, or
incarceration/correctional facilities. NHANES is an incredible tool that is utilized by
several governmental, research, academic and healthcare institutions. Examples of
NHANES data use being involved in endeavors includes pediatric growth charts being
consistently adapted for new reference standards, and blood lead data being involved in
governmental policy change for eliminating lead from gasoline, certain foods, and
aluminum cans available in the US.60
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ABSTRACT
ASSOCIATIONS BETWEEN ATHEROGENIC MARKERS AND HEARING LOSS:
NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY: 2011-2012,
2015-2016
Anna Rombakh
June 2022
Importance Hearing loss (HL) is a major public health problem that has been previously
found to be associated with abnormal atherogenic markers.
Objective To investigate the associations between such atherogenic markers and the
degree of HL using continuous NHANES data from cycle years 2011-2012 and 20152016.
Design, Study, and Participants This observational study used data from two National
Health and Nutrition Examination Survey (NHANES) cycle years 2011-2012 and 20152016. NHANES continuously conducts data collection via home interviews and physical
exams completed in their Mobile Examination Centers. NHANES participants ages 20-69
who partook in audiometry, anthropometric and laboratory testing were included. Data
was analyzed from 2011-2012 and 2015-2016 cycle years.
Exposures Substantial hearing loss was defined as as a HL degree of moderate (4155dB) or higher at any frequency.
Main Outcomes and Measures Risk of hypercholesterolemia was defined as ≥ 240
mg/dL, hypoalphalipoproteinemia or low levels of high-density lipoprotein cholesterol as
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< 40 mg/dL for males and < 50 mg/dL for females, elevated low-density lipoprotein
cholesterol as ≥ 160 mg/dL, hypertriglyceridemia was defined as ≥ 175 mg/dL, elevated
levels of Apolipoprotein B as ≥ 130 mg/dL and elevated non-high-density lipoprotein
cholesterol as ≥ 190 mg/dL. Associations between abnormal atherogenic markers and
substantial HL were determined in adjusted multivariate logistic regression models.
Results Among 8955 participants there were significant associations between gender,
age, BMI and race/ethnicity and substantial hearing loss (p < .0001). No significant
differences were identified between people with normal and substantial hearing loss in
regards to mean concentrations of total cholesterol, low-density lipoprotein cholesterol
(LDL-C), high-density lipoprotein cholesterol (HDL-C), non-high density lipoprotein
cholesterol (non-HDL-C), and apolipoprotein B cholesterol (ApoB). Significant
differences were identified between prevalence of triglycerides and substantial hearing
loss (p < .0001). Multivariate logistic regression models found that after adjusting for
covariates there was no significant association between having hypertriglyceridemia and
substantial hearing loss (OR 1.2, 95% CI, 0.8-1.8).
Conclusions and Relevance This study’s results showed no association between
atherosclerosis markers and degree of hearing loss. However, due to conflicting findings
of several studies on this topic, further research should be done to determine if lipid
markers can affect hearing loss.
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INTRODUCTION
In 2019, hearing loss (HL) affected an estimated 1.5 billion of the global
population, contributing to the third most common cause of years of living with disability
(YLDs).1 HL is commonly believed to be caused by noise exposure or aging, but still
largely remains a major public health problem with an unclear etiology. HL in midlife
has also been estimated to be associated with 9% of dementia cases, increasing an
individual’s level of cognitive impairment and leading to social isolation.2,3
HL can be caused by damage or dysfunction of the peripheral and/or central
auditory system from the external ear to the cerebral auditory cortex. HL type can be
categorized as sensorineural (cochlear or spiral ganglion impairment), conductive (outer
or inner ear impairment) or mixed.4 Mechanisms currently under investigation for HL
includes development of reactive oxygen species (ROS) and oxidative stress possibly
caused by antioxidant imbalances,5,6 and the “lipid hypothesis”. The current possible
explanation for the “lipid hypothesis” is that as atherosclerosis markers such as total
serum cholesterol elevate, blood viscosity will increase contributing to atherosclerosis of
arteries such as the internal auditory artery (IAA). The IAA is responsible for supplying
blood to the cochlea, auditory nerve, and the stria vascularis (SV) which is located at the
wall of the cochlea,7 When blood supply to the SV is constricted, vital nutrients are
unable to be supplied to hair cells, also known as stereocilia, leading to the irreversible
damage of hair cells and diminished hearing sensitivity.8 This type of damage has been
seen in numerous studies in individuals with cardiovascular disease, diabetes, chronic
kidney disease and in individuals with dyslipidemia.9-13 Similarly, an observational study
utilizing data from the National Health and Nutrition Examination Survey (NHANES)
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examining the relationship between risk factors of HL and diabetes identified that
individuals with low high-density lipoprotein and elevated total cholesterol where more
likely to be hearing impaired.9
The original study on this lipid hypothesis investigated hearing levels of
members of the southeast Sudan tribe, known as the Mabaans. Living in a noise-free
environment, researchers Rosen and colleagues sought out to research the possible
associations between vascular changes such as blood pressure and HL compared to
healthy adults living in the United States. Rosen et al., identified that there was a positive
inverse relationship with better hearing being associated with lowered cholesterol levels.
They also concluded that although noise exposure is an obvious and large component in
HL, other factors such as nutrition, vascular changes, stress, climate, and genetic factors
play a more significant role then previously known at the time. This inspired many to
continue examining the relationship of blood lipids and HL.14
In an experimental study done in 1997, Nguyen and Brownell identified that
lipidosis of the inner ear may be a mechanism of vascular changes affecting hearing.
Nguyen identified in guinea pig cochlea that hearing impairment can be attributed to the
varied blood cholesterol dispersals in the stereocilia tissues. When blood cholesterol is
integrated in stereocilia cells, lateral wall stiffness increases, contributing to hearing
impairment.15 Therefore, the purpose of this observational study was to investigate the
associations between such atherogenic markers and the degree of HL using continuous
NHANES data from cycle years 2011-2012 and 2015-2016.

31

METHODS
Study Population
This study used data from the National Health and Nutrition Examination Survey
(NHANES)16. NHANES, a cross sectional health study managed by the National Centers
for Health Statistics and is intended to assess the health status of individuals residing in
the United States. NHANES continuously conducts data collection via home interviews
and physical exams completed in their Mobile Examination Centers. This study utilized
data from cycle years 2011-2012 and 2015-2016 (most recent audiometry data available).
Participants in this study included individuals 20-69 years of age (audiometry
testing was only completed on those 20-69 years of age) who partook in both home
interviews and physical examinations from NHANES. Male and female participants were
included. Pregnant or lactating females were excluded from this study in addition to those
who did not receive audiometry testing.
Design and Procedures
This study analyzed audiometry examination data from pure tone air conduction
audiometry testing. Pure-tone audiometry signals were played to each ear at varying
intensities until the threshold at which the participant was just able to perceive the tone
were identified. Air conduction hearing thresholds in decibels hearing level (dB HL)
were obtained for each ear at 500, 1,000, 2,000, 3,000, 4,000, 6,000, and 8,000Hz by
trained audiometric technicians in NHANES Mobile Examination Centers.
Degree of HL was defined according to the American Speech Language Hearing
Association (ASHA) guidelines17. Degree of HL at any frequency was categorized the
ASHA with the following thresholds: normal hearing -10-15 dB, slight HL 16-25 dB,
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mild HL 26-40 dB, moderate HL 41-55 dB, moderately severe HL 56-70 dB, Severe HL
71-90 dB, and Profound HL >91 dB. Substantial HL was defined in this study as a HL
degree of moderate (41-55dB) or higher at any frequency.
Data was examined to observe the relationship between risk of abnormal blood
lipid values and degree of HL. Risk of hypercholesterolemia was defined as ≥ 240
mg/dL, hypoalphalipoproteinemia or low levels of high-density lipoprotein cholesterol as
< 40 mg/dL for males and < 50 mg/dL for females, elevated low-density lipoprotein
cholesterol as ≥ 160 mg/dL, hypertriglyceridemia was defined as ≥ 175 mg/dL, elevated
levels of Apolipoprotein B as ≥ 130 mg/dL and elevated non-high-density lipoprotein
cholesterol as ≥ 190 mg/dL18. The methodology used to determine these laboratory
values can be found on the NHANES webpage16. The following data was also collected
during the in-home interview or in the NHANES mobile examination center:
race/ethnicity, gender, age, weight, and body mass index (BMI).
Statistical Analysis
Data analysis was performed using the Statistical Analysis Software (SAS)
version 9.4 (SAS Institute Inc., Cary, North Carolina, USA). Descriptive statistics were
used to summarize characteristics such as mean and standard error. Chi-square analysis
was used to establish significant differences in prevalence of hearing loss and abnormal
blood lipids. Logistic regression models were used to establish odds ratios along with
crude and adjusted models (adjusted for confounding due to age, gender, BMI, or
ethnicity). T-test analyses were run to identify significant differences in the mean values
of age, BMI, or blood lipid concentrations between those with normal hearing and those
with substantial HL. Statistical significance was determined if p-value <0.05.
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RESULTS
Descriptive statistics of those with normal hearing and those with substantial HL
are shown in Table 1. Those with substantial HL were significantly older (mean = 56
years) compared to those with normal hearing (mean = 41 years) (Table 1, p <.0001). Of
females, 11% had substantial HL, while 24% of men had substantial HL (p < .0001).
There were significant differences found in the prevalence of substantial HL with
race/ethnicity, with 20% of NH-Whites with substantial HL (p < .0001), NH-Blacks
(11%), Mexican-Americans (13%), NH-Asians (13%) and other including multi-racial
ethnicity (16%). Body mass index (BMI) significantly higher for those with substantial
HL compared to normal hearing with an average BMI of 30 for those with substantial HL
(mean = 30.0) and for those with normal hearing (mean = 28.9, p < .0001).
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Table 1. Descriptive Statistics of Normal Hearing and Substantial Hearing Loss
Subjects. (+ SEM)
Normal Hearing
Total
Gender (%)
Female
Male
Age (years)
Race/Ethnicity (%)
Non-Hispanic Whites
Non-Hispanic Blacks
Mexican-Americans
Non-Hispanic Asians
Other
Body Mass Index
(kg/m2)
Atherogenic Markers
Total cholesterol
(mg/dl)
LDL-cholesterol
(mg/dl)
Non-HDL cholesterol
(mg/dl)
Apolipoprotein B
(mg/dl)
HDL cholesterol
(mg/dl)
Triglycerides (mg/dl)

82.3%

Substantial Hearing
Loss
17.7%

4555
4400

88.7 + 0.9
75.8 + 1.4
41.1 + 0.4

11.3 + 0.9
24.3 + 1.4
56.0 + 0.4

2785

79.8 + 1.3

20.2 + 1.3

2221
1300
1256
1393

89.0 + 0.7
86.6 + 1.2
87.3 + 2.0
83.8 + 1.8

11.0 + 0.7
13.4 + 1.2
12.7 + 2.0
16.2 + 1.7

< .0001

28.9 + 0.2

30.0 + 0.3

< .0001

3800

193.2 + 1.0

191.0 + 1.9

.4352

3740

115.4 + 0.8

111.4 + 1.6

.1227

3800

138.5 + 1.0

138.6 + 2.1

.2824

3798

91.5 + 0.7

93.1 + 1.3

.6714

3800

54.7 + 0.5

52.5 + 1.2

.6175

3798

116.7 + 2.1

141.0 + 7.8

< .0001

N
8955

p-value*

< .0001
< .0001

No significant differences were found between normal and substantial HL in
regard to mean concentrations of total serum cholesterol (TC), low-density lipoprotein
cholesterol (LDL-C), non-high-density lipoprotein cholesterol (Non-HDL-C),
Apolipoprotein B (ApoB) , and high-density lipoprotein cholesterol (HDL-C) when
analyzing prevalence of dyslipidemia (Table 2). In contrast, mean triglyceride
concentrations were 20.8% higher in individuals with substantial HL in contrast to
individuals with normal hearing (p < .0001).
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Similarly, there was no significant difference when analyzing prevalence of
dyslipidemia in normal hearing and substantial HL between elevated TC (12.4% vs.
11.3%), elevated LDL-C (10.1% vs. 7.7%), elevated non-HDL-C (10.9% vs. 12.3%),
elevated ApoB (7.7% vs 7.2%), and low HDL-C (33.0% vs. 33.8%). However,
prevalence of hypertriglyceridemia was significantly higher in those with substantial HL
compared to those with normal hearing (22.4% vs. 14.5%) (Table 2).
Table 2. Prevalence of Dyslipidemia in Normal Hearing and Significant Hearing
Loss Subjects.
p-value
N
Total
Total Cholesterol
(>240 mg/dl)
LDL Cholesterol
(>160 mg/dl)
Non-HDL Cholesterol
(> 190 mg/dl)
Apolipoprotein B
(> 130 mg/dl)
HDL-cholesterol
(< 40 mg/dl for males)
(< 50 mg/dl for
females)
Triglycerides
(> 175 mg/dl)

Normal Hearing
(% + SEM)

N

Substantial Hearing
Loss (% + SEM)

7401
833

12.4 + 0.7

1554
195

11.3 + 1.2

.4352

314

10.1 + 0.9

70

7.7 + 1.3

.1227

782

10.9 + 0.6

201

12.3 + 1.4

.2824

245

7.7 + 0.7

63

7.2 + 1.2

.6714

2645

33.0 + 1.0

577

33.8 + 2.0

.6175

458

14.5 + .9

145

22.4 + 2.6

< .0001

Simple logistic regression analysis of hypertriglyceridemia prevalence among
those with substantial HL showed that compared to young adults (20-39 years), middleaged adults (39-60 years) have a 2.4-fold (95% CI, 1.9-3.1, OR=2.4) increased odds of
having hypertriglyceridemia (Table 3). In contrast, older adults (60+ years) have a 1.8fold (95% CI, 1.2-2.8, OR=1.8) increased odds when compared to young adults. Logistic
regression analysis of hypertriglyceridemia prevalence and BMI category showed that
when compared to normal weight, overweight individuals were at a 3.4-fold (95% CI,
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2.4-4.6, OR=3.4) increased odds of having hypertriglyceridemia. Not surprisingly, obese
individuals were at a 5.0-fold (95% CI 3.7-6.4, OR=5.0) increased odds of having
hypertriglyceridemia when compared to those of a normal BMI. When compared to NHBlacks (lowest prevalence of substantial HL), NH-Whites were at a 2.6 fold (95% CI,
2.0-3.4, OR=2.6) increased odds, while Mexican-Americans were at a 3.0 (95% CI, 2.04.7, OR=3.0) increased odds, NH-Asians were at a 2.3 (95% CI, 1.6-3.3, OR=2.3)
increased odds and other including multi-racial having 2.5 fold (95% CI,1.6-3.7, OR=2.5)
increased odds of hypertriglyceridemia. Lastly, logistic regression analysis indicated that
there was a 70% (OR 1.7, 95% CI, 1.3-2.3) greater odds of having hypertriglyceridemia
in those with substantial HL when not adjusting for age, BMI, gender, or race/ethnicity
(Table 3).
Table 3. Simple Logistic Regression Analysis of Hypertriglyceridemia and
Individual Co-variates.
(Crude Model)
Hypertriglyceridemia
Odds Ratio (95% CI)
Age Group (ref = 20-39 years)
39-60 years
60+ years
Gender (ref = Female)
Male
BMI (ref = Normal (18.5-24.5kg/m2))
Underweight (18.5kg/m2)
Overweight (25-29.9kg/m2)
Obese (30+kg/m2)
Race/Ethnicity (ref = NH Black)
NH White
Mexican-Americans
NH Asians
Other including Multi-Racial
Substantial Hearing Loss vs. Normal
Hearing (ref= Normal Hearing)

2.4 (1.9-3.1) **
1.8 (1.2-2.8) **
1.8 (1.5-2.2)**
1.0 (0.5-2.2)
3.4 (2.4-4.6)**
5.0 (3.7-6.4)**
2.7 (2.0-3.4)**
3.0 (2.0-4.7)**
2.3 (1.6-3.3)**
2.5 (1.6-3.7)**
1.7 (1.3-2.3)**

Multivariate logistic regression analysis was conducted to examine the
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relationship between hypertriglyceridemia with the covariates of age group, sex, BMI
category, race/ethnicity, and HL. (Table 4) Using this model, middle-aged adults still had
a significant 2.2-fold (95% CI, 1.7-2.9) increased odds of having hypertriglyceridemia
compared to young adults. However, older adults’ odds of hypertriglyceridemia
decreased to a non-significant 1.5 fold (95% CI, 0.9-2.4) compared to 1.8 when
unadjusted. The odds of hypertriglyceridemia in men in this multivariate model was still
significantly greater in women (OR = 1.7, 95% CI, 1.3-2.2). The odds-ratio for
hypertriglyceridemia in overweight individuals decreased from 3.4 to 3.2 (95% CI, 2.34.4) odds when compared to normal weight individuals. There was no change for obese
individuals when compared to normal weight (OR 5.0, 95% CI, 3.6-6.8). There was no
significant change when analyzing race/ethnicity, except for NH Asians increased odds
from 2.3 to 4.2 (2.8-6.4) odds. When adjusting for the other covariates, the odds-ratio for
hypertriglyceridemia was no longer significant in those with substantial HL compared to
those with normal hearing (OR 1.2, 95% CI, 0.8-1.8).
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Table 4. Multivariate Regression Analysis of Hypertriglyceridemia and Degree of
Hearing Loss (Adjusted Model)
Hypertriglyceridemia
Odds Ratio (95% CI)
Age Group (ref = 20-39 years)
39-60 years
60+ years
Gender (ref = Female)
Male
BMI (ref = Normal (18.5-24.5kg/m2))
Underweight (18.5kg/m2)
Overweight (25-29.9kg/m2)
Obese (30+kg/m2)
Race/Ethnicity (ref = NH Black)
NH White
Mexican-Americans
NH Asians
Other-Including Multi-Racial
Substantial Hearing Loss vs. Normal
Hearing (ref= Normal Hearing)

2.2 (1.7-2.9) **
1.5 (0.9-2.4)
1.7 (1.3-2.2)**
1.2 (0.5-2.5)
3.2 (2.3-4.4)**
5.0 (3.6-6.8)**
2.6 (2.0-3.5) **
3.1 (2.0-4.7)**
4.2 (2.8-6.4)**
2.6 (2.0-3.5)**
1.2 (0.8-1.8)

DISCUSSION
This study revealed that elevated atherogenic markers were not associated with
substantial HL, except for elevated triglyceride levels. However, when the results were
adjusted for covariates of age, race/ethnicity, body mass index, and gender,
hypertriglyceridemia was no longer significantly associated with substantial HL. The
present study is one of several studies evaluating the relationship between blood lipid
markers and HL, thereby adding to the literature on this controversial topic.
The pioneers in this research topic, Rosen et al., published the original article in
1965 on the possible association between dyslipidemia and HL.19 They studied the
hearing levels of the remote Mabaan tribe (southeast Sudan), who resided in a reduced
noise environment compared to a control group of healthy adults in the United States.
They identified that there was a positive inverse relationship with better hearing being
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associated with lowered blood cholesterol levels. They also concluded that although noise
exposure is an obvious and large component in HL, other factors such as nutrition,
vascular changes, stress, climate, and genetic factors play a more significant role then
previously known at the time. Although the current study did not analyze nutrition, stress,
climate, or genetic factors, it was identified that age, BMI, gender, and race/ethnicity
were significantly associated with a higher odds of having hypertriglyceridemia, which
was discovered to be associated with substantial HL in the unadjusted model. In fact,
those with substantial HL had a 20.8% higher triglyceride mean concentration than those
with normal hearing levels.
Atherogenic markers examined in this present study can be used to determine risk
for cardiovascular disease (CVD). The large Nord-Trøndelag HL study (NTHLS), a large
population-based cohort study (n=31,547), Norwegians residing in the county of NordTrøndelag were recruited to participate in pure-tone audiometry testing and
questionnaires.20 The NTHLS study also examined the association between CVD risk
factors and HL. Those researchers concluded that although associations between HL and
risk factors was present, the results were unexpected. Surprisingly to these researchers it
was also identified that as HDL-C levels, LDL-C and TC increased, HL prevalence
decreased, indicating a possible protective effect of elevated blood lipids on HL.20
Consequently, elevated atherogenic markers may not be the main culprit of diminished
auditory function.
In 2011, Helzner et al., assessed the association between CVD and risk factors
with age-related HL (presbycusis) in a population of older black and white black and
adults.8 This cross-sectional cohort study recruited 2,049 healthy adults to undergo pure40

tone audiometry testing as well as establishing their CVD history and CVD risk factors.
Similarly, to the results of our study, Helzner and researchers found that elevated levels
of triglycerides and high BMI (especially among women) were significantly associated
with diminished auditory function. Consistent with Helzner et al. and our study’s results,
a European population based multi-national study analyzing risk factors for presbycusis,
identified that a higher BMI was associated with diminished hearing sensitivity.21
Mechanisms behind elevated BMI and increased risk of HL are not yet widely
understood in literature.22 Multiple studies have identified associations between elevated
BMI and higher prevalence of HL. Possible mechanisms include poor lifestyle choices
such as overconsumption of foods associated with increased risk of CVD, obesity and
diabetes23 and decreased levels of plasma adiponectin. Low levels of plasma adiponectin,
an anti-inflammatory adipokine has been associated with obesity,24 and involved in the
regulation of insulin sensitivity, metabolism and atherosclerosis.25 When elevated,
adiponectin has been linked to an inverse relationship with high-frequency HL, implying
that low levels may lead to HL.26 This relationship was proven in two experimental
animal studies conducted on mice.27,28
The first study, conducted by Wu et al., aimed to observe the function of
adiponectin in HL by examining genotypes associated with polymorphisms of the
adiponectin gene. Researchers recruited middle to older adult Han Chinese to form a
cohort for research on adiponectin genotypes, as well as mature mice utilized to confirm
hypotheses in this study’s experiment. Wu et al., identified that the adiponectin genotypes
show effects on hearing levels when plasma adiponectin levels fluctuate, and this finding
was further established in mice cochlea.27 Similarly, a study done by Tanigawa et al., was
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one of the first to show the relationship of adiponectin deficiency and HL in mice.
Tanigawa and researchers supplemented adiponectin to hyperlipidemic apolipoprotein Eknockout (APN-KO) mice and compared hearing threshold to wild-type mice (control).
Researchers identified that when APN-KO mice were supplemented with adiponectin,
HL was prevented, and multivariate logistic regression analysis indicated that adiponectin
was indeed an independent factor in predicting HL in mice.28
In the large Framingham study, researchers Gates et al., identified comparable
results to this study, in which no significant association was found between hearing levels
and triglyceride and total cholesterol levels in all genders after adjusting for covariates
such as age. Interestingly, they also identified that in women, there was a significant
inverse relationship with HDL levels and low frequency HL.29 Researchers Suzuki and
colleagues similarly identified no significant association between the impact of serum
lipid levels on hearing function between triglyceride and total cholesterol levels.30
Marlow et al., found that when assessing the relationship between HL and undetected
diseases such as hyperlipidemia, there was no significant difference between adults with
HL and adults with normal hearing.13
Results of this present study indicated that those with substantial hearing loss
were significantly older and more likely to be males, which may confound the
relationship between hypertriglyceridemia and HL. Hypertriglyceridemia has been
associated with being more likely to be elevated in males than in females, and in those of
an older age, as observed in an NHANES study monitoring CVD risk factors.31
Similar findings were identified in a 2006 study, in which Evans and researchers
examined the association with dyslipidemia and diminished auditory function. In this
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cross-sectional study, researchers found similar findings that older males were
significantly associated with HL.32 In a Japanese study evaluating the relationship
between dyslipidemia, diabetes, hypertension risk factors and hearing impairment also
identified that incidence of HL was elevated in men (31.5% vs 20.8%) and having two or
more risk factors for cardiovascular disease were found to be positively correlated with
hearing impairment (for males).33 In an large cohort study examining subclinical
atherosclerosis’ associations with hearing impairment, researchers found that risk of HL
was amplified for those whom are older, men and high BMI. Subclinical atherosclerosis,
evaluated by carotid artery intima media thickness and plaque, was also identified to be
associated with a 15% elevated risk of HL during a five year follow up.34 Males may be
more likely to have hearing loss as a recent study done in Canada indicated that men had
a significantly higher likelihood to have exposure to hazardous occupational noise.35
However, when associations between hyperlipidemia and noise-related HL were
examined by Demir et al., no significant relationship was identified.36 Nevertheless, after
adjustment to covariates, it is evident that it may be more vital to look at anthropometrics,
gender, and race/ethnicity when examining this association.
STRENGTHS AND LIMITATIONS
This present study’s strengths included large sample size and utilization of current
guidelines on blood cholesterol management for examination of prevalence and odds
ratios. Limitations of this study included a small number of cycle years used due to lack
of audiometry examination data available in recent years of NHANES. As with any
observational study only associations and not causation can be established. Lastly, prior
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research evaluating HL mentioned in this study, had varying thresholds for determining
degree of HL, proving it difficult to make concrete correlations.
CONCLUSIONS AND APPLICATIONS
This study’s results showed no association between atherosclerosis markers and
degree of hearing loss. While the prevalence of hypertriglyceridemia was greater in those
with hearing loss, after adjusting for age, sex, race/ethnicity and elevated BMI, the odds
of hypertriglyceridemia were not significantly greater in those with substantial hearing
loss compared to those with normal hearing. However, due to conflicting findings of
several studies on this topic, further research should be done to determine if lipid markers
can affect hearing loss.
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